Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
7
×
clinical trials
7
×
fda
life sciences
national blog main
san francisco blog main
7
×
san francisco top stories
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
startups
abbvie
drugs
eli lilly
novartis
biogen
bristol-myers squibb
cancer
cancer immunotherapy
celgene
What
bio
roundup
alzheimer’s
biotech
drug
drugs
fda
ipo
news
week
acquisitions
announced
annual
approved
assessed
attention
august
available
biological
biologics
biotechs
busy
can’t
cells
ceo
chose
clears
close
collabs
communities
companies
company
conference
congress
convenience
covid
daniel
days
deal
decisions
Language
unset
Current search:
astrazeneca
×
" clinical trials "
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way